Session Details

S030 Pearls Business and Leadership: What Dermatologists Should Know

Sat, Mar 20, 1:00 PM - 4:00 PM
3 CME Available Symposium Practice Management

DESCRIPTION

Medicine is one of the largest businesses in the world. Most medical training does not involve learning about this important topic. In this session, Dermatologists and trainees will learn practical pearls for success in various aspects of Dermatology, including medical, surgical, cosmetic, and dermatopathology practice, as well as coding and billing.

LEARNING OBJECTIVES

1.

Summarize key pearls for success in different areas of Dermatology practice, including medical, surgical, cosmetic, and dermatopathology.

2.

Outline important pearls in coding and billing for medical and surgical Dermatology.

3.

Recognize leadership perspectives and practical insights from experts in Dermatology and organized medicine.

SCHEDULE

1:00 PM

Pearls for Running a Successful Medical Dermatology Practice

Amy J. McMichael, MD, FAAD

1:14 PM

Pearls for Running a Successful Pediatric Dermatology Practice

Fernanda Bellodi Schmidt, MD

1:28 PM

Pearls for Running a Successful Dermatopathology Practice

Tammie C. Ferringer, MD, FAAD

1:42 PM

Pearls in Coding and Billing for Surgical Dermatology

Howard Wooding Rogers, MD, PhD, FAAD

1:56 PM

Pearls in Coding and Billing for Medical Dermatology

Dirk Michael Elston, MD, FAAD

2:10 PM

Pearls for Starting and Running a Solo Dermatology Practice

Suzanne McGoey, MD, MPH, FAAD

2:24 PM

Pearls for Running a Successful Surgical and Cosmetic Dermatology Practice

Roy G. Geronemus, MD, FAAD

2:38 PM

Pearls for Leading a Successful Dermatology Organization

Mark D. Kaufmann, MD, FAAD

2:52 PM

Pearls in Artificial Intelligence Applications in Dermatology

Faranak Kamangar, MD, FAAD

3:06 PM

Pearls in Teledermatology

George Han, MD, PhD, FAAD

3:20 PM

Leadership Pearls: Insights from a Former AMA President

Jack S. Resneck Jr., MD, FAAD

3:34 PM

How to Get More Involved with AAD Leadership

Marta Jane Van Beek, MD, MPH, FAAD

3:48 PM

Q&A

DIRECTOR

Keyvan Nouri, MBA, MD, FAAD

Keyvan Nouri, MBA, MD, FAAD

SPEAKERS

Fernanda Bellodi Schmidt, MD

Fernanda Bellodi Schmidt, MD

Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami

Dirk Michael Elston, MD, FAAD

Dirk Michael Elston, MD, FAAD

MUSC

Tammie C. Ferringer, MD, FAAD

Tammie C. Ferringer, MD, FAAD

Geisinger Medical Center

Roy G. Geronemus, MD, FAAD

Roy G. Geronemus, MD, FAAD

New York University

Faranak Kamangar, MD, FAAD

Faranak Kamangar, MD, FAAD

Kamangar Dermatology, DermGPT

Mark D. Kaufmann, MD, FAAD

Mark D. Kaufmann, MD, FAAD

Icahn School of Medicine at Mount Sinai

Suzanne McGoey, MD, MPH, FAAD

Suzanne McGoey, MD, MPH, FAAD

McGoey Dermatology

Amy J. McMichael, MD, FAAD

Amy J. McMichael, MD, FAAD

Wake Forest University School of Medicine

Jack S. Resneck Jr., MD, FAAD

Jack S. Resneck Jr., MD, FAAD

UCSF School of Medicine

Howard Wooding Rogers, MD, PhD, FAAD

Howard Wooding Rogers, MD, PhD, FAAD

Marta Jane Van Beek, MD, MPH, FAAD

Marta Jane Van Beek, MD, MPH, FAAD

DISCLOSURES

Fernanda Bellodi Schmidt, MD

Abeona Therapeutics – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Primus Pharmaceuticals – Advisory Board(Honoraria); Timber Pharmaceuticals – Investigator(Grants/Research Funding); VeraDermics Inc. – Advisory Board(Honoraria);

Dirk Michael Elston, MD, FAAD

No financial relationships exist with ineligible companies.

Tammie C. Ferringer, MD, FAAD

No financial relationships exist with ineligible companies.

Roy G. Geronemus, MD, FAAD

Accure, Inc – Stockholder Private Company(No Compensation Received); AVAVA, Inc. – Investigator(No Compensation Received); Sciton Inc. – Investigator(No Compensation Received);

Faranak Kamangar, MD, FAAD

No financial relationships exist with ineligible companies.

Mark D. Kaufmann, MD, FAAD

Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); CryoCaptures LLC – Stockholder Private Company(Stock); Dermsquared – Stockholder Private Company(Stock); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Genius Clinic, Inc – Stockholder Private Company(Stock Options); Incyte – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); NuVida – Advisory Board(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Peerwise Medical Corp – Stockholder Private Company(Stock); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); SciBASE – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees); Xtresse – Stockholder Private Company(Stock);

Suzanne McGoey, MD, MPH, FAAD

No financial relationships exist with ineligible companies.

Amy J. McMichael, MD, FAAD

Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);

Keyvan Nouri, MBA, MD, FAAD

iVeena Delivery Systems-Eye Drug Delivery – Stockholder(No Compensation Received); Pfizer Inc. – Stockholder(No Compensation Received);

Jack S. Resneck Jr., MD, FAAD

No financial relationships exist with ineligible companies.

Howard Wooding Rogers, MD, PhD, FAAD

Biofrontera AG – Consultant (1099 relationship)(Fees);

Marta Jane Van Beek, MD, MPH, FAAD

No financial relationships exist with ineligible companies.